UNSPSC 51151616: Atropine

This classification denotes an antimuscarinic agent with the molecular formula C17H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C0697DR9I, chemically known as 1alphah,5alphah-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate but generally known as atropine, which bears US NIH Compound Identifier 3661.

UNSPSC 51151616 Atropine is a Commodity code for individual pharmaceutical products supplied to state and local health agencies, emergency response programs, and health systems. Recent state and local solicitations show demand for naloxone and related emergency pharmaceuticals and drug-deactivation systems distributed through county health departments and state health agencies. Issuing bodies include county public health departments and state health and human services commissions pursuing community health initiatives, emergency preparedness, and pharmacy benefit program modernization. The work encompasses procurement of finished pharmaceutical units for inventory, quarterly or regular delivery to specified locations, and compliance with federal regulations when FEMA or other federal funding sources are involved.

Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through IFB 60459723LAS, with a due date of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission issued Request for Information HHS0017013 on April 3, 2026, to explore direct-to-manufacturer prescription and pharmaceutical supply models for a Therapeutic Pharmacy Initiative program, signaling state-level interest in alternative supply chain structures beyond traditional pharmacy benefit managers and wholesalers. Geographic activity includes Florida and Texas, representing both county-level public health procurement and state-level pharmacy program modernization. Vendors should anticipate requirements for electronic bidding portals, drug-free workplace certification, E-Verify compliance, and insurance coverage specifications including workers' compensation and professional liability.